This work also calls into
question neuroimaging studies that do not control for or report the time of day when scanning took place.
Not exact matches
REVEAL - SCAN: Risk Evaluation and and Education of Alzheimer's Disease - the
Study of Communicating Amyloid
Neuroimaging (RF1 AG047866) is the first multi-site, randomized clinical trial to examine the impact of learning amyloid imaging results in cognitively normal individuals, and its goal is to answer these
questions.
Given that the brain has potential for plasticity, many researchers
question whether sex differences found in
neuroimaging studies are because of biologically set, universal sex differences, or due to the influence of environmental or cultural factors on brain development (Fine, 2013).